Arca
Skip to content
Tools
Tools

Burn

Drug research and approvals for burn: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 19, 2026, 92 studies of burn are recruiting on ClinicalTrials.gov, Health Canada has authorized 5 drug trials for it since 2013, and FDA has 1 approved and 6 open orphan designations naming it.

  • Recruiting worldwide: 92
  • Trials authorized in Canada: 5
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting now

Newest posted first, of 92 recruiting on ClinicalTrials.gov ↗

How its trials ended

616 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 138 whose ending is known, 20% met their primary endpoint, 3% missed it and 77% stopped early.

  • Completed, result not reported26743%
  • Ongoing10918%
  • Status unknown10217%
  • Stopped: other or unclear6911%
  • Met its primary endpoint285%
  • Stopped: enrollment or feasibility244%
  • Stopped: sponsor or business decision61%
  • Missed its primary endpoint41%
  • Stopped: funding41%
  • Stopped: lack of efficacy3<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Apr 23, 2021A randomized, placebo controlled, double-blind, single dose study to evaluate the safety and tolerability of nefopam cream in burn patients with induced dermal…Nefopam (SCX-001)Governors of The University of AlbertaClosed
May 20, 2020A phase I, single-blind, randomized study of the safety and efficacy of cellularized integra® using autologous burn-derived stem cells.Integra®-scHamilton Health Sciences CorporationPending
May 8, 2017The effects of metformin on aging biomarkers, morbidity and mortality in burn patients - a prospective randomized controlled trial (RCT)MetforminHamilton Health Sciences CorporationOngoing
Dec 23, 2014Sass 2: reconstituted bilamellar autologous skin for permanenet covering of acute phase cutaneous wounds on major burn victimsBilayer autologous reconstructed skinCentre De Recherche Du Chu De QuebecOngoing
Oct 7, 2014Once daily aminoglycoside pharmacokinetics and optimal dosing in the burn population: a prospective studyTobramycinSunnybrook Research InstituteOngoing

FDA orphan designations

Approved first, then open designations, newest first
Jun 5, 1998Sulfamylon solutionFor use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts…Mylan Laboratories, Inc.Approved
Jun 14, 2021Genetically engineered (alpha-1,3-galactosyltransferase…Treatment of severe and extensive, deep partial and full-thickness burn wounds requiring hospitalization, surgical excision, and skin…XenoTherapeutics, Inc.Designated
Sep 6, 2016Bilayer, engineered collagen hydrogel-based skin graft…Treatment of partial deep dermal and full thickness burn woundsCurtiss AGDesignated
Jun 29, 2011Fibronectin PeptidePrevention of burn injury progression of acute, deep dermal burns in hospitalized patients.NeoMatrix Therapeutics, Inc.Designated
May 5, 2004IcatibantTreatment of burn patients hospitalized with burn-induced edemaShire Human Genetic TherapiesDesignated
Jan 28, 1997Dehydroepiandrosterone sulfate sodiumTo accelerate the re-epithelialization of donor sites in those hospitalized burn patients who must undergo autologous skin grafting.Pharmadigm, Inc.Designated
Mar 6, 1985Epidermal growth factor (human)For promotion of cutaneous wound healing in extreme burn treatment protocols.Ethicon, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.